Overview
- The wife and daughters of Ronald Biglione filed the claim in Federal Court in Río Cuarto before Judge Carlos Ochoa, seeking more than ARS 400 million in damages.
- The plaintiffs allege the 32-year-old developed thrombotic thrombocytopenic purpura days after a second AstraZeneca shot in September 2021 and died after 15 days in intensive care.
- According to the filing, a clinician reported the episode to Argentina’s ESAVI system as a possible vaccine adverse event, and the medical record noted that possibility.
- AstraZeneca expressed condolences, declined to comment on ongoing litigation, and said trials show an acceptable safety profile with benefits outweighing extremely rare risks.
- Local reports say it is the first case in Córdoba to allege a death linked to vaccination and follows two provincial suits over serious conditions after AstraZeneca doses, including Guillain-Barré.